Recombinant Escherichia coli O127:H6 Phosphoserine aminotransferase (serC)

Shipped with Ice Packs
In Stock

Description

Recombinant Production and Purification

Recombinant SerC is typically produced in E. coli expression systems (e.g., BL21 strains) using plasmids like pET15b, which enable N-terminal His-tag fusion for affinity purification .

Key Steps:

  1. Cloning: The serC gene is amplified from E. coli O127:H6 E2348/69 (GenBank: FM180568) and inserted into an expression vector .

  2. Expression: Induced with IPTG, yielding soluble enzyme in high amounts .

  3. Purification: Metal-affinity chromatography achieves >85% purity, confirmed via SDS-PAGE .

Kinetic Parameters (Wild-Type SerC)8

ParameterValue
KmK_m (Phosphoserine)5 μM
VmaxV_{max}1.35 μmol/min/mg
pH Optimum7.5–8.0

Functional Insights and Mutational Studies

  • Asp100Ala Mutation: Reduces solubility by ~10-fold and lowers VmaxV_{max} to 15% of wild-type activity, underscoring Asp100’s role in structural stability .

  • Metabolic Role: SerC links serine biosynthesis to pyridoxine production, as serC mutants require serine and pyridoxine supplementation .

Applications in Biotechnology

  1. Genetic Code Expansion:

    • E. coli ΔserC strains are used to host orthogonal translation systems for incorporating non-hydrolyzable phosphoserine analogs into proteins .

    • Recombinant SerC restores serine biosynthesis in these strains, enabling cell viability during protein engineering .

  2. Enzyme Engineering:

    • Used to study phosphorylation mimicry in signaling pathways .

Genomic Context in E. coli O127:H6

The serC gene in E. coli O127:H6 E2348/69 is located on its 4.97 Mb chromosome (Gene ID: B7UP81) . Comparative genomics reveals conserved operon structures across pathogenic E. coli strains, though virulence factors (e.g., T3SS) are absent in SerC’s genomic region .

Research Challenges

  • Instability: Recombinant phosphoproteins require SerC-deficient hosts to avoid enzymatic dephosphorylation .

  • Structural Dynamics: The dimeric interface and PLP-binding site remain targets for improving thermal stability .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have specific format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional charges will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to ensure contents are at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C is recommended. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you have a specific tag type requirement, please inform us, and we will prioritize developing it.
Synonyms
serC; E2348C_0900; Phosphoserine aminotransferase; EC 2.6.1.52; Phosphohydroxythreonine aminotransferase; PSAT
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-362
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli O127:H6 (strain E2348/69 / EPEC)
Target Names
serC
Target Protein Sequence
MAQIFNFSSG PAMLPAEVLK QAQQELRDWN GLGTSVMEVS HRGKEFIQVA EEAEKDFRDL LNVPSNYKVL FCHGGGRGQF AAVPLNILGD KTTADYVDAG YWAASAIKEA KKYCTPNVFD AKVTVDGFRA VKPMSEWQLS DNAAYMHYCP NETIDGIAID ETPNFGKDVV VAADFSSTIL SRPIDVSRYG VIYAGAQKNI GPAGLTIVIV REDLLGKANI ACPSILDYSI LNDNDSMFNT PPTFAWYLSG LVFKWLKANG GVVAMDKINQ QKAELLYGVI DNSDFYRNDV AKANRSRMNV PFQLADSALD KLFLEESFAA GLHALKGHRV VGGMRASIYN AMPLEGVKAL TDFMVEFERR HG
Uniprot No.

Target Background

Function
Catalyzes the reversible conversion of 3-phosphohydroxypyruvate to phosphoserine and 3-hydroxy-2-oxo-4-phosphonooxybutanoate to phosphohydroxythreonine.
Database Links
Protein Families
Class-V pyridoxal-phosphate-dependent aminotransferase family, SerC subfamily
Subcellular Location
Cytoplasm.

Q&A

What is phosphoserine aminotransferase (serC) and what is its metabolic role in E. coli?

Phosphoserine aminotransferase (SerC) is a critical enzyme in the serine biosynthetic pathway of E. coli. It catalyzes the second step in the three-step phosphorylated pathway, specifically the conversion of 3-phosphohydroxypyruvate to 3-phosphoserine using glutamate as an amino donor. This reaction is essential for de novo serine biosynthesis in bacteria. SerC requires pyridoxal 5'-phosphate (PLP) as a cofactor for its aminotransferase activity .

The serC gene is part of the serC-aroA operon in E. coli, which notably contains genes involved in two distinct amino acid biosynthetic pathways - serine and aromatic amino acids. This unusual organization suggests complex metabolic integration between these pathways in E. coli .

How is the serC gene organized and regulated in the E. coli genome?

The serC gene in E. coli exists as part of the serC-aroA operon, which contains genes encoding enzymes for both serine and aromatic amino acid biosynthesis. This represents an unusual organization where genes from unrelated biosynthetic pathways are co-regulated .

Research utilizing a serC-aroA-lac translational fusion constructed in vector pMC1403 has demonstrated that the expression of this operon is positively controlled by cyclic AMP (cAMP). Experimental evidence shows enhanced synthesis of β-galactosidase from this fusion when lactose is the sole carbon source. This enhancement disappears in strains with cya (adenylate cyclase) or crp (cAMP receptor protein) mutations, confirming cAMP-dependent regulation .

Furthermore, the exogenous addition of cAMP significantly increases β-galactosidase synthesis in cya mutant strains, and dot blot assays show increased serC-aroA mRNA content in serC+ aroA+ cells after cAMP addition .

What are the structural and functional characteristics of SerC protein?

The SerC protein belongs to the aminotransferase class V family and adopts a fold typical of PLP-dependent enzymes. The active site contains a conserved lysine residue that forms a Schiff base with the PLP cofactor during catalysis. The enzyme functions as a homodimer in solution, with each monomer containing one active site.

The catalytic mechanism involves:

  • Binding of the PLP cofactor to the enzyme

  • Formation of a Schiff base between PLP and a conserved lysine residue

  • Transimination with the amino donor (glutamate)

  • Transfer of the amino group to 3-phosphohydroxypyruvate

  • Release of 3-phosphoserine and regeneration of the enzyme-PLP complex

Optimal enzymatic activity occurs at pH 7.5-8.0 and temperatures around 37°C, typical for E. coli cytoplasmic enzymes.

What expression systems are optimal for recombinant SerC production?

For standard recombinant SerC production, E. coli BL21(DE3) or similar expression strains are commonly employed with vectors containing T7 or tac promoters. These systems typically yield 10-20 mg of purified SerC per liter of culture under optimized conditions.

For specialized applications involving phosphoserine incorporation into recombinant proteins, engineered strains with genomic modifications have been developed. The most effective systems include:

  • B95(DE3) ΔA ΔfabR ΔserB - This RF1-deficient strain with a serB knockout produces phosphoserine internally at high levels and is preferred for "truncation-free" expression with higher yields .

  • BL21(DE3) ΔserB - A standard strain with serB knockout that requires serine supplementation but still produces phosphoserine internally .

These specialized strains can yield approximately 100-200 mg of phosphoserine-containing proteins per liter of culture when using rich auto-induction media, without requiring exogenous phosphoserine supplementation .

How can I optimize expression conditions for maximum yield and activity of recombinant SerC?

To optimize recombinant SerC expression, consider the following methodological approaches:

Media selection:

  • Rich auto-induction media significantly improves yields compared to standard IPTG induction in LB media .

  • For serB knockout strains (serine auxotrophs), media must be supplemented with serine (typically 0.5-1 mM) .

Temperature modulation:

  • Initial growth at 37°C to OD600 of 0.6-0.8, followed by induction

  • Post-induction expression at lower temperatures (16-25°C) for 16-24 hours improves protein solubility

Cofactor addition:

  • Supplementing media with pyridoxal 5'-phosphate (50-100 μM) can enhance the proportion of active enzyme

Induction parameters:

  • For IPTG-inducible systems, concentrations of 0.1-0.5 mM IPTG are typically optimal

  • For auto-induction, careful formulation of carbon sources is critical for timed expression

Codon optimization:

  • Synthetic genes with codons optimized for E. coli expression can increase yields by 2-3 fold

What purification strategies yield the highest purity and activity for recombinant SerC?

A multi-step purification strategy is recommended for obtaining high-purity, active SerC:

Step 1: Affinity Chromatography

  • His-tagged SerC can be purified using Ni-NTA or TALON resin

  • Wash with 10-20 mM imidazole to remove weakly bound proteins

  • Elute with 250-300 mM imidazole gradient

  • All buffers should contain 0.1-0.2 mM PLP to maintain cofactor association

Step 2: Ion Exchange Chromatography

  • DEAE or Q-Sepharose columns at pH 7.5-8.0

  • Linear NaCl gradient (0-500 mM) for elution

  • SerC typically elutes at 200-250 mM NaCl

Step 3: Size Exclusion Chromatography

  • Superdex 200 or similar resins separate dimeric SerC from aggregates and contaminants

  • Running buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.1 mM PLP

This protocol typically yields >95% pure SerC with specific activity of 5-10 μmol/min/mg protein in standard assay conditions.

How does serB deletion affect phosphoserine metabolism and recombinant protein production?

The deletion of serB gene, which encodes phosphoserine phosphatase, creates a metabolic block that prevents the conversion of 3-phosphoserine to serine. This genetic modification has several significant consequences:

  • Accumulation of phosphoserine: Internal phosphoserine levels increase substantially, enabling its incorporation into recombinant proteins .

  • Serine auxotrophy: ΔserB strains cannot synthesize serine and require exogenous supplementation for growth. This auxotrophy must be addressed in culture media formulations .

  • Enhanced phosphoprotein production: When combined with genetic code expansion systems (using orthogonal aminoacyl-tRNA synthetase/tRNA pairs), these strains enable site-specific incorporation of phosphoserine into recombinant proteins at yields of 100-200 mg per liter of culture .

  • Metabolic rebalancing: The cell metabolism adapts to the block in the serine pathway, potentially affecting other interconnected metabolic networks, including amino acid and central carbon metabolism.

This genetic modification serves as the foundation for the production of recombinant phosphoproteins without requiring kinases, allowing researchers to produce milligram quantities of homogeneously modified proteins for downstream studies .

What experimental approaches can verify successful serC expression and activity?

Several complementary methods can be employed to assess SerC expression and activity:

Spectrophotometric enzyme assay:

  • Follow the conversion of 3-phosphohydroxypyruvate to 3-phosphoserine by coupling to NADH oxidation

  • Typically conducted at 340 nm, pH 7.5, 37°C

  • Activity calculated using ε340 of 6,220 M^-1 cm^-1 for NADH

SDS-PAGE and western blot analysis:

  • Protein expression verification using anti-SerC antibodies or tag-specific antibodies

  • Densitometric analysis for quantification

Mass spectrometry:

  • LC-MS/MS for protein identification and confirmation of post-translational modifications

  • Intact mass analysis to verify full-length protein production

Growth complementation assay:

  • Functional verification by complementation of serC-deficient E. coli strains

  • Comparison of growth rates in minimal media with and without serine supplementation

Activity quantification table:

Test conditionExpected activity (μmol/min/mg)Detection method
Purified SerC5-10NADH-coupled assay
Crude extract0.5-2NADH-coupled assay
Cell lysate0.05-0.2LC-MS substrate conversion

How can serC mutations be used to study the serine biosynthetic pathway?

Site-directed mutagenesis of serC provides valuable insights into enzyme mechanism and pathway regulation:

Catalytic residue mutations:

  • K197A: Eliminates Schiff base formation with PLP, abolishing activity

  • R82A: Disrupts substrate binding, reducing catalytic efficiency

  • D168A: Affects proton transfer, altering reaction kinetics

Regulatory domain mutations:

  • Mutations in potential allosteric sites can reveal pathway feedback mechanisms

  • C-terminal modifications may affect protein-protein interactions

Experimental approaches:

  • Create a library of serC point mutants using site-directed mutagenesis

  • Express and purify mutant proteins

  • Characterize kinetic parameters (kcat, Km) for each mutant

  • Perform complementation assays in serC-deficient strains

  • Analyze growth phenotypes under different nutritional conditions

  • Conduct metabolomic analysis to identify pathway intermediates

These studies help elucidate the structure-function relationships in SerC and its role in the broader metabolic network.

How can recombinant SerC be used to study enzyme mechanisms and regulation?

Recombinant SerC serves as an excellent model system for investigating fundamental aspects of enzyme catalysis and regulation:

Steady-state kinetic analysis:

  • Determine Km, kcat, and kcat/Km for both 3-phosphohydroxypyruvate and glutamate

  • Assess substrate cooperativity through Hill coefficient determination

  • Investigate potential inhibitors and activators

Transient-state kinetics:

  • Use stopped-flow spectroscopy to identify reaction intermediates

  • Determine rate constants for individual steps in the catalytic cycle

  • Characterize the formation and breakdown of the Schiff base intermediates

Ligand binding studies:

  • Isothermal titration calorimetry (ITC) to measure binding thermodynamics

  • Fluorescence spectroscopy to monitor conformational changes upon substrate binding

  • Surface plasmon resonance (SPR) for real-time binding analysis

Regulation mechanisms:

  • Investigate potential post-translational modifications that affect activity

  • Examine protein-protein interactions with other metabolic enzymes

  • Study the impact of cellular metabolites on enzyme activity

These approaches provide comprehensive insights into SerC's catalytic mechanism and its integration within bacterial metabolism.

What role does SerC play in phosphoserine incorporation systems for recombinant proteins?

While SerC itself catalyzes the formation of phosphoserine in the serine biosynthetic pathway, the phosphoserine incorporation system for recombinant proteins operates through a distinct mechanism involving genetic code expansion:

  • The ΔserB strain accumulates phosphoserine due to blocked conversion to serine .

  • An orthogonal translation system is introduced, consisting of:

    • An engineered aminoacyl-tRNA synthetase that recognizes phosphoserine

    • A specialized tRNA with an amber anticodon

    • A target protein gene containing strategically placed TAG (amber) codons

  • During translation, the orthogonal system incorporates phosphoserine at TAG codons, while the endogenous SerC continues to function in its native biosynthetic role .

This genetic code expansion approach enables the production of homogeneously phosphorylated proteins at yields of 100-200 mg per liter of culture, which can be purified for downstream applications in studying phosphorylation-dependent signaling systems and protein-protein interactions .

How can SerC be utilized in metabolic engineering of E. coli strains?

SerC manipulation offers several strategies for metabolic engineering applications:

Serine overproduction:

  • Overexpression of serC alongside other serine pathway enzymes can enhance serine production

  • Co-expression with feedback-resistant 3-phosphoglycerate dehydrogenase (serA) increases pathway flux

  • Deletion of competing pathways can redirect carbon flux toward serine production

Metabolic pathway balancing:

  • Fine-tuning serC expression levels can modulate the balance between serine and aromatic amino acid biosynthesis

  • Adjusting the serC:aroA ratio can optimize metabolic flux distribution

Synthetic biology applications:

  • Integration of serC into synthetic operons for novel metabolic pathways

  • Engineering SerC variants with altered substrate specificity for non-natural amino acid production

  • Creation of biosensors based on serC promoter activity for monitoring cellular metabolic state

Strain optimization strategy table:

Engineering goalGenetic modificationsExpected outcome
Serine overproductionserC and serA overexpression, competing pathway deletion5-10 fold increase in serine
Phosphoserine accumulationserB deletion, serC overexpressionHigh intracellular phosphoserine
Aromatic amino acid productionBalanced serC-aroA expressionEnhanced aromatic amino acid synthesis

What techniques can resolve contradictory findings about SerC structure and function?

When facing conflicting data regarding SerC structure or function, several advanced techniques can help resolve discrepancies:

Integrative structural biology approaches:

  • Combine X-ray crystallography, cryo-EM, and NMR to obtain a comprehensive structural model

  • Use hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map protein dynamics and conformational changes

  • Employ small-angle X-ray scattering (SAXS) to characterize solution structure

Functional validation through complementary methods:

  • Develop multiple independent activity assays that measure different aspects of the reaction

  • Use isotope labeling to track atom transfer during catalysis

  • Apply single-molecule techniques to study enzyme behavior at the individual molecule level

Computational validation:

  • Perform molecular dynamics simulations to assess structural stability and conformational states

  • Use quantum mechanics/molecular mechanics (QM/MM) calculations to model reaction mechanisms

  • Develop machine learning models to predict effects of mutations on enzyme function

Systematic assessment of experimental conditions:

  • Test activity across a wide range of pH, temperature, and ionic strength conditions

  • Examine the effects of different buffer components on enzyme behavior

  • Investigate time-dependent changes in enzyme activity and stability

These multidisciplinary approaches can help reconcile conflicting observations and establish a consensus model of SerC structure and function.

How might SerC function differ between pathogenic and non-pathogenic E. coli strains?

Comparative analysis of SerC between pathogenic E. coli O127:H6 and non-pathogenic laboratory strains reveals potential adaptations relevant to virulence:

Genetic analysis:

  • Sequence comparison shows subtle amino acid variations that may affect enzyme efficiency

  • Promoter region differences suggest altered regulation in response to host environments

  • Potential horizontal gene transfer events may have influenced serC evolution in pathogenic strains

Expression patterns:

  • Transcriptomic data indicates differential expression of serC under host-mimicking conditions

  • Response to stress conditions may vary between pathogenic and non-pathogenic strains

  • Integration with virulence gene expression networks may occur in pathogenic strains

Metabolic adaptations:

  • Pathogenic strains may utilize SerC to optimize amino acid metabolism during infection

  • Connection between serine metabolism and virulence factor production

  • Potential role in adapting to nutritional limitations within host environments

Experimental approaches for comparison:

  • Compare serC sequence, structure, and kinetic parameters between strains

  • Analyze expression patterns under infection-relevant conditions

  • Perform metabolomic profiling to identify strain-specific metabolic signatures

  • Test cross-complementation between pathogenic and non-pathogenic serC variants

  • Investigate protein-protein interaction networks in different strain backgrounds

These studies may reveal how SerC has evolved to support pathogen-specific metabolic requirements.

What are the current technical challenges in studying SerC-mediated phosphoserine metabolism?

Several technical challenges complicate the comprehensive study of SerC and phosphoserine metabolism:

Analytical limitations:

  • Difficulty in precise quantification of phosphoserine due to its chemical instability

  • Challenges in distinguishing between protein-incorporated and free phosphoserine

  • Need for specialized mass spectrometry methods for accurate phosphometabolite analysis

Genetic system constraints:

  • Lethality of certain serC modifications requires careful conditional expression systems

  • Potential polar effects on aroA expression when manipulating serC

  • Metabolic burden of overexpression systems affecting physiological relevance

Methodological barriers:

  • Limited availability of phosphoserine standards for analytical method development

  • Challenges in maintaining enzyme activity during purification due to cofactor loss

  • Difficulty in tracking intracellular phosphoserine fluxes in real-time

Research direction opportunities:

  • Development of genetically encoded biosensors for intracellular phosphoserine monitoring

  • Application of metabolic flux analysis with isotope labeling to map phosphoserine pathways

  • Creation of conditional expression systems for studying essential serC functions

  • Engineering of more stable SerC variants for structural and functional studies

  • Integration of multi-omics approaches to understand system-level effects of serC manipulation

Addressing these challenges will enable more comprehensive understanding of SerC's role in bacterial metabolism and its potential applications in biotechnology and medicine.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.